Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma

NCT00084656 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Intraocular Melanoma
Melanoma (Skin)

Interventions

BIOLOGICAL: ipilimumab
BIOLOGICAL: Tyrosinase/gp100/MART-1 Peptides

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]